All Online

1 - 12 of 32 results


Active filters


This Expert Perspective highlights the salient points of the joint Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), published in 2012, on the management of hyperglycemia in type 2 diabetes.

vitamins in the palm of your hand

The aim of this program is to examine the cardiovascular effects of pharmacotherapies used in managing type 2 diabetes with a focus on key clinical trials regarding the use of diabetes medications in patients with established or at elevated risk for cardiovascular disease.


For a growing number of patients with diabetes, concentrated insulins may be the ideal agents in order to best address challenges of insulin resistance while improving health outcomes. However, the unique properties of these agents mean that each form of concentrated insulin serves a specific function in the overall management of diabetes. It is critical that clinicians are comfortable distinguishing concentrated insulins and selecting ideal patients for treatment as an intimate knowledge of these agents will allow clinicians to optimize treatment and reduce risks. In this interactive case-based roundtable discussion, expert faculty will guide learners through overcoming barriers associated with insulin use, distinguishing among approved concentrated insulin products, identifying patients who would benefit from concentrated insulin therapy, and employing best practices in management in order to minimize risks such as hypoglycemia.

The primary goal of this integrated, multi-interventional curriculum of both live and online activities is to provide an educational initiative for primary care physicians, physician assistants (PAs) and nurse practitioners (NPs) on the advantages and disadvantages of prandial insulin, the clinical profiles of GPL-1 receptor agonists, and the benefits of combining GLP-1 receptor agonists with basal insulin.


This activity is part of the ConnectED Learning: Diabetes curriculum. Join expert faculty as they address your remaining questions and provide a distillation of clinical pearls from the ConnectED Learning Curriculum on the management of diabetes


This case outlines nuances of intensifying therapy with oral antidiabetic agents based on patient and disease characteristics


This activity is part of the ConnectED Learning: Diabetes curriculum. This case will highlight best practices of intensifying therapy with oral combination regimens in individuals with T2DM.


This activity is part of the ConnectED Learning: Diabetes curriculum. In this Expert Perspective, Dr. Richard Pratley outlines the main facets of utilizing oral combination therapy to intensify treatment in order to achieve HbA1c goals while minimizing side effects and cardiovascular risk.


This activity is part of the ConnectED Learning: Diabetes curriculum. It is well proven that effective glycemic control among patients with type 2 diabetes can reduce the risk of diabetes-related microvascular and macrovascular complications. This dynamic live educational program will feature renowned faculty experts who will lead an interactive discussion on important evidence supporting emerging clinical strategies, shared decision making, and ways in which to individualize care to best manage the complex challenges of diabetes and the progression of disease. It will include therapeutic approaches that can reduce the risks such as hypoglycemia, weight gain, and cardiovascular events.